Steward Partners Investment Advisory LLC Purchases Shares of 111,496 Alignment Healthcare, Inc. $ALHC

Steward Partners Investment Advisory LLC acquired a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 2nd quarter, HoldingsChannel reports. The firm acquired 111,496 shares of the company’s stock, valued at approximately $1,561,000.

A number of other large investors also recently modified their holdings of ALHC. Invesco Ltd. grew its holdings in Alignment Healthcare by 1,415.7% during the first quarter. Invesco Ltd. now owns 1,875,790 shares of the company’s stock worth $34,927,000 after buying an additional 1,752,033 shares in the last quarter. Vanguard Group Inc. lifted its stake in Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock valued at $206,941,000 after acquiring an additional 1,295,825 shares in the last quarter. 8 Knots Management LLC boosted its holdings in Alignment Healthcare by 28.9% during the 1st quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company’s stock worth $87,802,000 after acquiring an additional 1,056,777 shares during the last quarter. Voya Investment Management LLC grew its stake in shares of Alignment Healthcare by 408.3% in the 1st quarter. Voya Investment Management LLC now owns 1,293,414 shares of the company’s stock worth $24,083,000 after acquiring an additional 1,038,940 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in shares of Alignment Healthcare by 124.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,869,035 shares of the company’s stock worth $26,166,000 after acquiring an additional 1,037,638 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Trading Up 0.9%

Shares of ALHC opened at $19.40 on Friday. Alignment Healthcare, Inc. has a fifty-two week low of $10.18 and a fifty-two week high of $21.06. The business has a 50-day moving average of $17.22 and a 200 day moving average of $15.54. The firm has a market cap of $3.88 billion, a P/E ratio of -161.63 and a beta of 1.17. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company’s quarterly revenue was up 43.5% on a year-over-year basis. During the same quarter last year, the business earned ($0.14) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insiders Place Their Bets

In other news, insider Christopher J. Joyce sold 30,939 shares of the firm’s stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the completion of the transaction, the insider directly owned 343,592 shares of the company’s stock, valued at $5,638,344.72. This trade represents a 8.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the business’s stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total value of $99,999,996.96. Following the sale, the director owned 24,596,079 shares in the company, valued at approximately $393,783,224.79. The trade was a 20.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 7,582,116 shares of company stock worth $122,276,938 in the last three months. Insiders own 7.00% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ALHC. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. JPMorgan Chase & Co. upgraded shares of Alignment Healthcare from a “neutral” rating to an “overweight” rating and increased their price target for the company from $18.00 to $20.00 in a research report on Monday, November 24th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, UBS Group increased their target price on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $20.05.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.